Dunhill Financial’s Pediatrix Medical MD Stock Holding History

Dunhill Financial’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36	Hold	1	–	–	﹤0.01%	1550
2026 Q1	$30	Hold	1	–	–	﹤0.01%	1708
2025 Q4	$31	Buy	+1	New	+$20	﹤0.01%	1809

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dunhill Financial's MD Position: Q2 2026 in Review

Dunhill Financial held its Pediatrix Medical (MD) position steady in Q2 2026 at 1 share worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

Dunhill Financial first reported a position in MD in Q4 2025 and has held it in 3 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Dunhill Financial held 1 share of Pediatrix Medical worth $36 as of Q2 2026.
Dunhill Financial left its Pediatrix Medical share count unchanged in Q2 2026.
Pediatrix Medical made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1550 holding.
Dunhill Financial first reported a position in Pediatrix Medical in Q4 2025 and has held it in 3 quarters since.
304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.